Pharmaceutical policy in the UK involves a trade-off between the interest of the National HealthService in controlling expenditure on drugs and the interest of the pharmaceutical industry inproviding an incentive for research and development. Since 1957, the Pharmaceutical PriceRegulation Scheme...